RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information1st July 2026
Summary: This MHRA blog examines the potential of in-orbit manufacturing to produce medicines that are difficult or impossible to create on Earth. By taking advantage of the unique microgravity environment, researchers hope to improve the production of complex medicines, including biologics and advanced therapies. The article outlines the regulatory challenges associated with manufacturing beyond Earth and explains how the MHRA is working with partners to help develop appropriate regulatory approaches, supporting innovation while ensuring the quality, safety and efficacy of medicines produced in space.